2-巯基噻唑啉，CAS 登记号 96-53-7，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-巯基噻唑啉 的 CAS 号：96-53-7，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-Mercaptothiazoline · CAS 96-53-7 · C3H5NS2. UNII UPA7Y8938Q.
| CAS Registry Number | 96-53-7 |
|---|---|
| PubChem CID | 2723699 |
| Molecular formula | C3H5NS2 |
| IUPAC name | 1,3-thiazolidine-2-thione |
| UNII (FDA) | UPA7Y8938Q |
| Molecular Weight | 119.21 |
|---|---|
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 118.98634151 |
| Monoisotopic Mass | 118.98634151 |
| Topological Polar Surface Area | 69.4 |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Regulatory & Food Contact | FDA Inventory of Food Contact Substances Listed in 21 CFR: FCS |
|---|
| Reported hazard statements | H301 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
2-Mercaptothiazoline; 96-53-7; 1,3-Thiazolidine-2-thione; 2-Thiazolidinethione; 2-Mercapto-2-thiazoline; Metabasal; Thyroidan; 2-Thiothiazolidone; Mercaptothiazoline; Sancelent 2MT; 4,5-Dihydro-2-mercaptothiazole; Tetrahydrothiazole-2-thione; 2(3H)-Thiazolethione, 4,5-dihydro-; WR 305; UPA7Y8938Q; NSC-680
CAS 96-53-7; molecular formula C3H5NS2; molecular weight — g/mol.
2-Mercaptothiazoline, 96-53-7, 1,3-Thiazolidine-2-thione, 2-Thiazolidinethione, 2-Mercapto-2-thiazoline, Metabasal.
Documented regulatory listings: FDA Inventory of Food Contact Substances Listed in 21 CFR: FCS.
Hazard statements reported: H301.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.